Home > Financial Ratios > BETA DRUGS

BETA DRUGS
EV/Net Sales

    Back to All Ratios
BETA DRUGS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for BETA DRUGS
Please provide your vote to see the results

BETA DRUGS Last 5 Year EV/Net Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Net Sales(x) 5.283.962.662.981.05

What is the latest EV/Net Sales ratio of BETA DRUGS ?

The latest EV/Net Sales ratio of BETA DRUGS is 5.28 based on Mar2025 Consolidated results.
Year EV/Net Sales
Mar20255.28
Mar20243.96
Mar20232.66
Mar20222.98
Mar20211.05

How is EV/Net Sales of BETA DRUGS Trending?

Years EV/Net Sales % Change
Mar2025 5.28
33.33
Mar2024 3.96
48.87
Mar2023 2.66
-10.74
Mar2022 2.98
183.81
Mar2021 1.05 -

Other Financial Ratios of BETA DRUGS


Compare EV/Net Sales ratio of peers of BETA DRUGS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BETA DRUGS ₹2,627.3 Cr 7.4% 14.4% 37.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹467,630.0 Cr -2.6% 2.4% 14.6% Stock Analytics
DIVIS LABORATORIES ₹221,666.0 Cr 6.5% 23.3% 25.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹190,108.0 Cr 2.6% 3% 33.5% Stock Analytics
CIPLA ₹117,139.0 Cr -1.1% -0.2% -7.9% Stock Analytics
DR REDDYS LABORATORIES ₹97,990.9 Cr 2.6% -13.3% -10.7% Stock Analytics


BETA DRUGS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BETA DRUGS

7.4%

14.4%

37.5%

SENSEX

1.2%

0.4%

-2.9%


You may also like the below Video Courses